Skip to content
About Us
Vision & Mission
Founder/CEO Message
Leadership
Quality
CSR
Meaning of Sapala
Ownership
Services
By Area
Nucleic Acid Chemistry
Medicinal Chemistry
Carbohydrate Chemistry
Lipid and GalNAc Chemistry
Fluorescent Chemistry
By Engagement
CRO – FTE
CDMO – FFS
Analytical Services
Customized Model
By Industry
Academia
Start-ups (Biotech)
Oligo CDMOs
Therapeutic Companies
mRNA Vaccine Innovators
Sequencing Tech Makers
Products
Nucleoside and Phosphoramidites Derivatives
Linkers and Spacers
PEG Derivatives
Miscellaneous Products
Careers
Contact Us
Structure Search
Menu
About Us
Vision & Mission
Founder/CEO Message
Leadership
Quality
CSR
Meaning of Sapala
Ownership
Services
By Area
Nucleic Acid Chemistry
Medicinal Chemistry
Carbohydrate Chemistry
Lipid and GalNAc Chemistry
Fluorescent Chemistry
By Engagement
CRO – FTE
CDMO – FFS
Analytical Services
Customized Model
By Industry
Academia
Start-ups (Biotech)
Oligo CDMOs
Therapeutic Companies
mRNA Vaccine Innovators
Sequencing Tech Makers
Products
Nucleoside and Phosphoramidites Derivatives
Linkers and Spacers
PEG Derivatives
Miscellaneous Products
Careers
Contact Us
Structure Search
Products
Search
Search
Nucleoside and Phosphoramidites Derivatives
Linkers and Spacers
Other Products
PEG Derivatives
3′-Deoxy adenosine
SNP-0001
73-03-3
Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)C[C@H]3O
Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)C[C@H]3O
1-((2R,3R,4R,5R)-3-Hydroxy-5-(hydroxymethyl)-4-methoxytetra hydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
SNP-0002
1555759-15-3
CO[C@@H]2[C@@H](O)[C@H](n1cc(C)c(=O)[nH]c1=O)O[C@@H]2CO
CO[C@@H]2[C@@H](O)[C@H](n1cc(C)c(=O)[nH]c1=O)O[C@@H]2CO
1-((2R,3R,4R,5R)-3-Hydroxy-5-(hydroxymethyl)-4-methoxytetrahydro furan-2-yl)pyrimidine-2,4(1H,3H)-dione
SNP-0003
6038-59-1
CO[C@@H]2[C@@H](O)[C@H](n1ccc(=O)[nH]c1=O)O[C@@H]2CO
CO[C@@H]2[C@@H](O)[C@H](n1ccc(=O)[nH]c1=O)O[C@@H]2CO
4-Amino-1-((2R,3R,4R,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetra hydrofuran-2-yl)pyrimidin-2(1H)-one
SNP-0004
1555759-09-5
CO[C@@H]2[C@@H](O)[C@H](n1ccc(N)nc1=O)O[C@@H]2CO
CO[C@@H]2[C@@H](O)[C@H](n1ccc(N)nc1=O)O[C@@H]2CO
N-(1-((2R,3R,4R,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
SNP-0005
1555759-60-8
CO[C@H]3[C@@H](O)O[C@@H](N2CC/C(NC(=O)c1ccccc1)=N\C2=O)[C@@H]3O
CO[C@H]3[C@@H](O)O[C@@H](N2CC/C(NC(=O)c1ccccc1)=N\C2=O)[C@@H]3O
(2R,3R,4R,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol
SNP-0006
10300-22-8
CO[C@H]3[C@@H](O)O[C@@H](n2cnc1c(N)ncnc12)[C@@H]3O
CO[C@H]3[C@@H](O)O[C@@H](n2cnc1c(N)ncnc12)[C@@H]3O
N-(9-((2R,3R,4R,5R)-3-Hydroxy-5-(hydroxymethyl)-4-methoxytetra hydrofuran-2-yl)-9H-purin-6-yl)benzamide
SNP-0007
NA-70
CO[C@H]4[C@@H](O)O[C@@H](n3cnc2c(NC(=O)c1ccccc1)ncnc23)[C@@H]4O
CO[C@H]4[C@@H](O)O[C@@H](n3cnc2c(NC(=O)c1ccccc1)ncnc23)[C@@H]4O
1-((2R,3S,4R,5R)-4-Fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
SNP-0008
917110-29-3
Cc2cn([C@@H]1O[C@H](CO)[C@H](F)[C@H]1O)c(=O)[nH]c2=O
Cc2cn([C@@H]1O[C@H](CO)[C@H](F)[C@H]1O)c(=O)[nH]c2=O
1-((2R,3S,4R,5R)-4-Fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
SNP-0009
NA-71
O=c2ccn([C@@H]1O[C@H](CO)[C@H](F)[C@H]1O)c(=O)[nH]2
O=c2ccn([C@@H]1O[C@H](CO)[C@H](F)[C@H]1O)c(=O)[nH]2
4-Amino-1-((2R,3S,4R,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
SNP-0010
26563-01-9
Nc2ccn([C@@H]1O[C@H](CO)[C@H](F)[C@H]1O)c(=O)n2
Nc2ccn([C@@H]1O[C@H](CO)[C@H](F)[C@H]1O)c(=O)n2
(2R,3S,4R,5R)-2-(6-Amino-9H-purin-9-yl)-4-fluoro-5-(hydroxymethyl) tetrahydrofuran-3-ol
SNP-0012
20535-16-4
Nc1ncnc2c1ncn2[C@@H]3O[C@H](O)[C@H](F)[C@H]3O
Nc1ncnc2c1ncn2[C@@H]3O[C@H](O)[C@H](F)[C@H]3O
N-(9-((2R,3S,4R,5R)-4-Fluoro-3-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
SNP-0013
132849-69-5
O=C(Nc1ncnc2c1ncn2[C@@H]3O[C@H](O)[C@H](F)[C@H]3O)c4ccccc4
O=C(Nc1ncnc2c1ncn2[C@@H]3O[C@H](O)[C@H](F)[C@H]3O)c4ccccc4
Load More